Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

240
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

231
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
231
Ethical Dilemmas I01:17

Ethical Dilemmas I

1.8K
Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Respiratory Syncytial Virus Immunization Disparities in Mothers and Infants at the Birth Hospitalization: A Cross-Sectional Study.

The Journal of pediatrics·2026
Same author

Assessing risk for hemolytic hyperbilirubinemia in newborns: direct antiglobulin test versus end-tidal carbon monoxide.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Comfort, benefit, and distress: An exploratory study of research experiences of bereaved parents in the neonatal intensive care unit.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Tiered Approach to Clonidine Dosing to Prevent Dexmedetomidine Withdrawal in Children: A Prospective Pre and Post Interventional Cohort Study.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026
Same author

Styles of communication in the intensive care unit: Nudges and recommendations.

Journal of critical care·2026
Same author

A National Quality Improvement Collaborative to Reduce Subthreshold Phototherapy for Jaundice.

Pediatrics·2026

Related Experiment Video

Updated: Jan 8, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K

Neonatal Toxicology Testing: Ethical Considerations for Pediatricians.

Christine M Gold1, Leela Sarathy2, Jayme Congdon3

  • 1University of Colorado, Denver, Colorado.

Hospital Pediatrics
|December 16, 2025
PubMed
Summary
This summary is machine-generated.

Neonatal toxicology testing (NTT) for prenatal substance exposure can harm newborns and families. Ethical frameworks can guide pediatricians to create supportive, equitable care policies, reducing bias and family separation.

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.3K
Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.6K

Related Experiment Videos

Last Updated: Jan 8, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.3K
Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.6K

Area of Science:

  • Neonatal care
  • Toxicology
  • Medical ethics

Background:

  • Pediatricians manage newborns with prenatal substance exposure and neonatal opioid withdrawal syndrome (NOWS).
  • Neonatal toxicology testing (NTT) is commonly used for NOWS identification and management.
  • Current NTT practices exhibit variability, leading to negative consequences for newborns and families.

Purpose of the Study:

  • To highlight ethical principles and frameworks for managing newborns with prenatal substance exposure.
  • To inform clinical practice and policies related to NTT.
  • To reduce variability and inequity in NTT and optimize newborn and family well-being.

Main Methods:

  • Review of ethical principles and frameworks relevant to NTT.
  • Analysis of current NTT practices and their impact on newborns and families.
  • Discussion of pediatrician's role in policy and practice change.

Main Results:

  • Variability in NTT practices perpetuates bias, inequity, and family separation.
  • Ethical frameworks can align medical care and legislative requirements.
  • Supportive, rather than punitive, approaches are needed for care.

Conclusions:

  • Pediatricians should critically examine NTT practices and hospital policies.
  • Developing supportive care models can improve outcomes for exposed newborns and families.
  • Ethical considerations are crucial for equitable and effective NTT.